Scarica l'app Stockscreener
22.86
1.15%
-0.2699
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché TNDM Giù?
Forum
Previsione
Frazionamento azionario
Tandem Diabetes Care Inc Borsa (TNDM) Ultime notizie
Tandem Diabetes Care subsidiary earns new FDA clearance for insulin infusion set - MassDevice
Tandem Diabetes Care gets FDA clearance for new set By Investing.com - Investing.com Nigeria
Tandem Diabetes Care gets FDA clearance for new set - Investing.com
Tandem's Initial Growth Spurt From the Launch of Mobi Should Moderate in the Near Term - Morningstar
Investor Network: Tandem Diabetes Care, Inc. to Host Earnings Call - ACCESS Newswire
INVESTOR ALERT: Levi & Korsinsky Notifies Tandem Diabetes Care, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline – TNDM - ACCESS Newswire
INVESTOR ALERT: Levi & Korsinsky Notifies Tandem Diabetes Care, Inc. Investors of a Class Action Lawsuit and Upcoming DeadlineTNDM - ACCESS Newswire
SHAREHOLDER ALERT: Levi & Korsinsky Notifies Shareholders of Tandem Diabetes Care, Inc.(TNDM) of a Class Action Lawsuit and an Upcoming Deadline - ACCESS Newswire
INVESTOR ALERT: Levi & Korsinsky Reminds Tandem Diabetes Care, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of November 7, 2023TNDM - ACCESS Newswire
INVESTOR ALERT: Levi & Korsinsky Reminds Tandem Diabetes Care, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of November 7, 2023 – TNDM - ACCESS Newswire
Diabetes segment reports good news all around - BioWorld MedTech
Tandem Diabetes Care Announces Upcoming Conference Presentations - BioSpace
BlackRock, Inc. Reduces Stake in Tandem Diabetes Care Inc - GuruFocus
Insulin Pump Market Poised for 8.3% CAGR Growth Through 2033 - openPR.com
Earnings Release: Here's Why Analysts Cut Their Tandem Diabetes Care, Inc. (NASDAQ:TNDM) Price Target To US$35.52 - simplywall.st
Tandem Diabetes jumps as overseas sales drive Q1 beat - MSN
Tandem Diabetes Care, Inc. (TNDM) Reports Q1 Loss, Tops Revenue Estimates - MSN
Tandem Diabetes Care, Inc. (NASDAQ:TNDM) Q1 2025 Earnings Call Transcript - Insider Monkey
TNDM Stock Rises Despite Q1 Earnings Miss, Gross Margin Up - Yahoo Finance
Tandem Diabetes Care First Quarter 2025 Earnings: Revenues Beat Expectations, EPS Lags - Yahoo Finance
Tandem Diabetes Care (TNDM): Analyst Maintains "Buy" Rating and Raises Target Price | TNDM Stock News - GuruFocus
Tandem Diabetes (TNDM) Shares Surge on Robust Q1 Revenue - GuruFocus
Tandem Diabetes Care Reports Record Sales and Strategic Growth - TipRanks
Tandem Diabetes stock jumps on Q1 results (TNDM:NASDAQ) - Seeking Alpha
Tandem Diabetes Care (TNDM) Target Price Lowered by Wells Fargo - GuruFocus
TNDM: Stifel Adjusts Price Target for Tandem Diabetes Care | TND - GuruFocus
TNDM: Piper Sandler Adjusts Price Target Amid Overweight Rating - GuruFocus
TNDM: Baird Maintains Neutral Rating, Lowers Price Target | TNDM Stock News - GuruFocus
Canaccord raises Tandem Diabetes Care target to $59 - Investing.com
Tandem Diabetes Care Stock: A Deep Dive Into Analyst Perspectives (10 Ratings) - Benzinga
Tandem Diabetes (TNDM) Sees Price Target Reduced by Baird | TNDM Stock News - GuruFocus
Tandem Diabetes (TNDM) Price Target Raised by Canaccord Amid Pro - GuruFocus
Tandem Diabetes (TNDM) Target Price Revised as Analysts Remain O - GuruFocus
Tandem Diabetes (TNDM) Price Target Adjusted by Analyst | TNDM S - GuruFocus
Tandem Diabetes Care Inc (TNDM) Q1 2025 Earnings: Revenue Surpas - GuruFocus
Tandem Diabetes Care Inc (TNDM) Q1 2025 Earnings Call Highlights: Record Sales and Strategic ... - Yahoo Finance
Tandem Diabetes Care Reports 22.3% Revenue Increase in Q1 CY2025News and Statistics - IndexBox
Tandem Diabetes Care Inc (TNDM) Q1 2025 Earnings Call Highlights - GuruFocus
Tandem's (TNDM) Strong Q1 Revenue Surpasses Expectations | TNDM Stock News - GuruFocus
Tandem Diabetes Care (TNDM) Q1 Earnings: How Key Metrics Compare to Wall Street Estimates - Yahoo Finance
Tandem Diabetes Care Announces First Quarter 2025 Financial Results - BioSpace
Earnings call transcript: Tandem Diabetes Care Q1 2025 Misses EPS, Stock Rises - Investing.com
Tandem Diabetes’s (NASDAQ:TNDM) Q1: Beats On Revenue, Stock Soars - Yahoo Finance
Tandem Diabetes Q1 2025 slides: dual-platform strategy targets underpenetrated market - Investing.com
Tandem Diabetes (NASDAQ:TNDM) Posts Better-Than-Expected Sales In Q1, Stock Soars - Yahoo Finance
Tandem Diabetes stock surges on revenue beat, strong guidance By Investing.com - Investing.com Nigeria
2.09%
2.24%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):